An Observational Study to Investigate the Incidence of Influenza and Influenza-related Complications, in Adults Between 50-64 Years and Elderly Adults 65 Years and Over Vaccinated With Fluarix™
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 29 Sep 2011 Additional locations identified as reported by ClinicalTrials.gov.
- 12 May 2008 The expected completion date for this trial is now 1 Jun 2007.
- 11 May 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.